Epidemiological characteristics and molecular basis of fluoroquinolone-resistant Neisseria gonorrhoeae strains isolated in Korea and nearby countries

Journal of Antimicrobial Chemotherapy

Volumn 54, Issue 2, 2004, Pages 451-455

  Yong, Dongeun ^a   Kim, Tae Sook ^a   Choi, Jong Rak ^a   Yum, Jong Hwa ^a   Lee, Kyungwon ^a   Chong, Yunsop ^a   Oh, Hee Bok ^b   Shultz, Tiffany ^c   Tapsall, John W ^c  

^a Yonsei University College of Medicine   (South Korea)

^b Korea National Institute of Health   (South Korea)

^c PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Ciprofloxacin; N. gonorrhoeae; Pulsed field gel electrophoresis; QRDRs; Resistance

Indexed keywords

AMINO ACID; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; PROTEIN PARC; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLINICAL OBSERVATION; CONTROLLED STUDY; HUMAN; KOREA; MINIMUM INHIBITORY CONCENTRATION; MUTATIONAL ANALYSIS; NEISSERIA GONORRHOEAE; NONHUMAN; PREVALENCE; PULSED FIELD GEL ELECTROPHORESIS;

AMINO ACID SUBSTITUTION; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; DNA GYRASE; DNA MUTATIONAL ANALYSIS; DNA TOPOISOMERASE IV; ELECTROPHORESIS, GEL, PULSED-FIELD; EPIDEMIOLOGY, MOLECULAR; FLUOROQUINOLONES; GONORRHEA; HUMANS; KOREA; MICROBIAL SENSITIVITY TESTS; NEISSERIA GONORRHOEAE;

EID: 4444248485     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh345     Document Type: Article

References (17)

1. Centers for Disease Control and Prevention. (2002). Sexually transmitted diseases treatment guidelines 2002. Morbidity and Mortality Weekly Report 51, 36-7.
2. WHO Western Pacific Gonococcal Antimicrobial Surveillance Programme. (1998). Resistance in gonococci isolated in the WHO Western Pacific region to various antimicrobials used in the treatment of gonorrhea, 1997. Communicable Diseases Intelligence 22, 288-91.
3. Tanaka, M., Nakayama, H., Haraoka, M. et al. (2000). Antimicrobial resistance of Neisseria gonorrhoeae and high prevalence of ciprofloxacin-resistant isolates in Japan, 1993 to 1998. Journal of Clinical Microbiology 38, 521-5.
4. Kam, K. M., Lo, K. K., Ho, N. K. et al. (1995). Rapid decline in penicillinase-producing Neisseria gonorrhoeae in Hong Kong associated with emerging 4-fluoroquinolone resistance. Genitourinary Medicine 71, 141-4.
5. Fox, K. K., Knapp, J. S., Holmes, K. K. et al. (1997). Antimicrobial resistance in Neisseria gonorrhoeae in the United States, 1988-1994: the emergence of decreased susceptibility to fluoroquinolones. Journal of Infectious Diseases 175, 1396-403.
6. Lee, K., Chong, Y., Erdenechemeg, L. et al. (11998). Incidence, epidemiology and evolution of reduced susceptibility to ciprofloxacin in Neisseria gonorrhoeae in Korea. Clinical Microbiology and Infection 4, 627-33.
7. Lee, K., Shin, J. W., Lim, J. B. et al. (2000). Emerging antimicrobial resistance, plasmid profile and pulsed-field gel electrophoresis pattern of the endonuclease-digested genomic DNA of Neisseria gonorrhoeae. Yonsei Medical Journal 41, 381-6.
8. Knapp, J. S. & Koumans, E. H. (1999). Neisseria and Branhamella. In Manual of Clinical Microbiology, 7th edn (Murray, P. R., Baron, E. J., Pfaller, M. A. et al., Eds), pp. 586-603. ASM press, Washington, DC, USA.
9. National Committee for Clinical Laboratory Standards. (1997). Performance Standards for Antimicrobial Disk Susceptibility Tests - Sixth Edition: Approved Standard M2-A6. NCCLS, Wayne, PA, USA.
10. National Committee for Clinical Laboratory Standards (1997). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Fourth Edition: Approved Standard M7-A4. NCCLS, Wayne, PA, USA.
11. Shultz, T. R., Tapsall, J. W. & White, P. A. (2001). Correlation of in vitro susceptibilities to newer quinolones of naturally occurring quinolone-resistant Neisseria gonorrhoeae strains with changes in GyrA and ParC. Antimicrobial Agents and Chemotherapy 45, 734-8.
12. The WHO Western Pacific Gonococcal Antimicrobial Surveillance Programme. (2001). Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2000. Communicable Diseases Intelligence 25, 274-6.
13. Trees, D. L., Sirivongrangson, P., Schultz, A. J. et al. (2002). Multiclonal increase in ciprofloxacin-resistant Neisseria gonorrhoeae, Thailand, 1998-1999. Sexually Transmitted Diseases 29, 668-73.
14. Belland, R. J., Morrison, S. G., Ison, C. A. et al. (1994). Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates. Molecular Microbiology 14, 371-80.
15. Su, X. & Lind, I. (2001). Molecular basis of high-level ciprofloxacin resistance in Neisseria gonorrhoeae strains isolated in Denmark from 1995 to 1998. Antimicrobial Agents and Chemotherapy 45, 117-23.
16. Yagupsky, P., Schahar, A., Peled, N. et al. (2002). Increasing incidence of gonorrhoea in Israel associated with countrywide dissemination of a ciprofloxacin-resistant strain. European Journal of Clinical Microbiology and Infectious Diseases 21, 368-72.
17. Lkhamsuren, E., Shultz, T. R., Limnios, E. A. et al. (2001). The antibiotic susceptibility of Neisseria gonorrhoeae isolated in Ulaanbaatar, Mongolia. Sexually Transmitted Infections 77, 218-9.